Retrospective Evaluation of Liposarcoma

Survival , Tumor Clinical Trial

— RELiSa  

Official title:

Retrospective Evaluation of Liposarcoma

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03034252
• Other study ID #: 448/11
• Status: Completed
• Phase: N/A
• First received: January 22, 2017
• Last updated: January 25, 2017
• Start date: January 2016
• Est. completion date: January 2017

Study information

• Verified date: January 2017
• Source: Technische Universität München
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Retrospective Evaluation of Survival after Liposarcoma

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: January 2017
• Est. primary completion date: January 2017
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Patients with Liposarcoma treated surgically at our clinic

Exclusion Criteria:

Related Conditions & MeSH terms

• Liposarcoma
• Survival , Tumor

Intervention

Procedure:
• Patients with Liposarcoma
Evaluation of Liposarcoma treated in a single center

Locations

Country	Name	City	State
Germany	Klinikum rechts der Isar	Munich	Bavaria

Sponsors (1)

Lead Sponsor	Collaborator
Technische Universität München

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Survival rate		2 years